Clinipace Worldwide CEO Resigns

Jeff Williams, co-founder, president, and CEO of Clinipace Worldwide, a global full-service clinical research organization (CRO) that he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, who will assume the role of CEO. Williams will remain a director and will focus on strategic initiatives on behalf of the Board of Directors. 
 
Williams started the company in 2003 with the desire to leverage technology in new ways to improve the way clinical research is conducted. Today, the company is one of the top 15 CROs in the industry and employs more than 800 employees worldwide. 

“I am extremely proud of what we have built at Clinipace, but the time has come for me to replace myself and it is my pleasure to welcome Jason Monteleone as CEO,” said Williams. “After seeing him in action as a consultant to Clinipace over the last several months, I am confident he will build successfully on our company’s 14-year history and lead us into its next phase of growth.”  
 
Monteleone, who has most recently founded Pivotal Financial Consulting LLC, a strategic financial consulting firm serving the clinical research industry with a special focus on CROs, stated, “I am honored to join Clinipace on the heels of the remarkable accomplishments that Jeff and his organization have achieved. I am confident that the strong foundation he built, and the talented team here, will serve us well as we continue our quest to make Clinipace the leading mid-market CRO.” 
 
Monteleone has more than 20 years of experience in clinical research, life science, and healthcare-related organizations. He has also been executive vice president and chief financial officer (CFO) of Theorem Clinical Research, CFO of Omnicare Clinical Research, senior finance director of MDS Pharma Services, and finance director at VIASYS Healthcare. He holds an MBA in finance from the Fox School of Business and Management at Temple University and a bachelor of science degree in business administration from Millersville University of Pennsylvania.
 
Clinipace Worldwide, a global full-service clinical research organization, serves the unique needs of venture-backed, mid-tier, and strategic pharmaceutical, biotechnology, and medical device firms, helping to advance drug candidates to deliver successful stakeholder and patient outcomes. The company leverages therapeutic knowledge and clinical trial expertise to support life science firms in achieving their most important goals: executing regulatory strategies, optimizing clinical development timelines, and completing high-quality trials. Clinipace has completed more than 1,500 clinical trials and 1,500 regulatory and statistical consulting projects and operates in North America, South America, Europe, and Asia Pacific.